University Hospital Greifswald
Welcome,         Profile    Billing    Logout  
 14 Trials 
24 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Greinacher, Andreas
LIBERAL, NCT03369210: Liberal Transfusion Strategy in Elderly Patients

Recruiting
3
2470
Europe
red blood cell transfusion trigger
Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital
Transfusion-dependent Anemia, Surgery, Anemia
12/24
12/25
Felix, Stephan B
HOMEX-HF-P, NCT02051712: Cardiovascular Effects of Preferred Home-based Exercise Training in Systolic Heart Failure

Recruiting
3
120
Europe
exercise training, Adherence measures
University Medicine Greifswald, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Chronic Heart Failure
07/24
12/24
TRINITY, NCT05570409 / 2021-005875-38: Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

Recruiting
2/3
130
Europe
Mycophenolate Mofetil, MMF, Prednisolone, Mycophenolate Mofetil Placebo, MMF Placebo, Prednisolone Placebo
LMU Klinikum, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Technical University of Munich, Charite University, Berlin, Germany, University Hospital, Essen, University Hospital Erlangen, University Hospital Tuebingen
Inflammatory Cardiomyopathy
03/27
03/28
NCT00558584: Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy

Completed
N/A
180
Europe, RoW
protein A immunoadsorption, pseudo-immunoadsorption
University Medicine Greifswald, Krupp von Bohlen und Halbach-Foundation, Essen, Germany, ENDI-Foundation, Bad Homburg, Germany, Bristol-Myers Squibb
Dilated Cardiomyopathy
09/21
04/23
GANIFU-Card, NCT02970214: Follow-up of GANI_MED Cardio Cohorts

Recruiting
N/A
1200
Europe
no intervention, only observational
University Medicine Greifswald
Chronic Heart Failure, Metabolic Syndrome
12/24
12/24
Lode, Holger
HIT-HGG-2013, NCT03243461 / 2013-004187-56: International Cooperative Phase III Trial of the HIT-HGG Study Group

Recruiting
3
167
Europe
Temozolomide + Valproic Acid
University of Göttingen, Deutsche Kinderkrebsstiftung, Hannover Medical School
Glioblastoma WHO Grade IV, Diffuse Midline Glioma Histone 3 K27M WHO Grade IV, Anaplastic Astrocytoma WHO Grade III, Diffuse Intrinsic Pontine Glioma, Gliomatosis Cerebri
12/23
12/23
AIEOP-BFM ALL 2017, NCT03643276 / 2016-001935-12: Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia -

Recruiting
3
5000
Europe, RoW
Blinatumomab, Bortezomib, Cyclophosphamide, Cytarabine, Daunorubicin, Myocet, Dexamethasone, Doxorubicin, Etoposide, Fludarabine Phosphate, Ifosfamide, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Tioguanin, Vincristine, Vindesine, Erwinase
Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany)
Acute Lymphoblastic Leukemia, Pediatric
07/28
07/28
FORUM, NCT01949129 / 2012-003032-22: Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia

Recruiting
2/3
1800
Europe, Canada, RoW
VP16, Etoposide, TBI, Thiotepa, Thio, Treosulfan, Treo, Fludarabine, Flu, Busulfan, Bu, ATG Thymoglobulin, ATG Thymo, Cyclophosphamide, Cy, Grafalon, Anti-human T-lymphocyte immunoglobulin
St. Anna Kinderkrebsforschung, ALL SCTped Forum, European Society for Blood and Marrow Transplantation, ALL-BFM Study Group, Assistance Publique - Hôpitaux de Paris, Dutch Childhood Oncology Group, Swiss Pediatric Oncology Group, Australian & New Zealand Children's Haematology/Oncology Group
Acute Lymphoblastic Leukaemia
06/25
04/30
APN311-304, NCT02743429 / 2014-000588-42: Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Active, not recruiting
2
40
Europe
dinutuximab beta
University Medicine Greifswald, Children's Cancer Research Institute, Austria
Neuroblastoma
12/23
06/24
DBPilot, NCT06485947: Study Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma

Not yet recruiting
1
38
Europe
Dinutuximab beta, Immunotherapy, chemotherapy treatment called GPOH, chemotherapy treatment called rapid COJEC
Princess Maxima Center for Pediatric Oncology, EUSA Pharma, Inc.
Neuroblastoma
07/30
12/31
NCT04253015: A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta

Recruiting
N/A
125
Europe
Data-collection
EusaPharma (UK) Limited, United BioSource, LLC
Neuroblastoma
03/32
06/32
Doerr, Marcus
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
Selleng, Sixten
LIBERAL, NCT03369210: Liberal Transfusion Strategy in Elderly Patients

Recruiting
3
2470
Europe
red blood cell transfusion trigger
Johann Wolfgang Goethe University Hospital, Wuerzburg University Hospital
Transfusion-dependent Anemia, Surgery, Anemia
12/24
12/25
Hilgendorf, Ingo
TRINITY, NCT05570409 / 2021-005875-38: Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy

Recruiting
2/3
130
Europe
Mycophenolate Mofetil, MMF, Prednisolone, Mycophenolate Mofetil Placebo, MMF Placebo, Prednisolone Placebo
LMU Klinikum, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK), Technical University of Munich, Charite University, Berlin, Germany, University Hospital, Essen, University Hospital Erlangen, University Hospital Tuebingen
Inflammatory Cardiomyopathy
03/27
03/28
Kohl, Stefan
DOUBLE_PROTECT, NCT05944016: Phase 3 Clinical Trial with Dapagliflozin in Chronic Kidney Disease in Adolescents and Young Adult Patients

Recruiting
3
102
Europe
Dapagliflozin, Placebo
University Hospital Goettingen, German Research Foundation
Chronic Kidney Failure in Children and Young Adults
09/26
12/26
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33
Strake, Sylvia
FOrMe, NCT03949972: The Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)

Recruiting
N/A
500
Europe
Biosampling
Prof. Dr. Paul Brinkkoetter, German Research Foundation, Medical Faculty and the Faculty of Natural Sciences of the University of Cologne, Cluster of Excellence on Cellular Stress Responses in Ageing-Associated Diseases, Cologne Center for Genomics
Glomerulosclerosis, Focal Segmental, Minimal Change Disease, Idiopathic Nephrotic Syndrome
03/28
03/33
Chamling, Bishwas
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
Bruder, Michael
MYOFLAME-19, NCT05619653: Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19

Recruiting
3
280
Europe
Prednisolone, Losartan
Valentina Puentmann, Bayer, Alcedis GmbH
COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction, Exercise Intolerance, Vascular Inflammation, Microvascular Angina
12/24
12/28
Divard, Gillian
SHORTCUT, NCT05597540 / 2022-002319-43: Efficacy of 7 Days Versus 14 Days of Antibiotic Therapy for Acute Pyelonephritis in Kidney Transplant Recipients, a Multicentre Randomized Non-inferiority Trial.

Recruiting
3
470
Europe
Short antibiotic treatment, Usual antibiotic treatment
Assistance Publique - Hôpitaux de Paris, DGOS
Pyelonephritis Acute, Kidney Transplant Infection
03/27
08/27
TAK-620-5010, NCT06615921: A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Recruiting
N/A
150
Europe, RoW
No Intervention
Takeda
Cytomegalovirus (CMV)
04/25
04/25
Schwarzer, Adrian
IMPACT-AML, NCT06713837: A Randomized Pragmatic Clinical Trial for Relapsed or Refractory Acute Myeloid Leukemia.

Not yet recruiting
3
339
Europe, RoW
High intensity therapies, Low intensity therapies
Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori, Hospital Vall d'Hebron, Cyprus Institute of Neurology and Genetics, European Leukemia Net, Fundacion Para La Investigacion Hospital La Fe, Ostdeutsche Studiengruppe Haematologie Und Onkologie e.V., Ospedale Pediatrico Bambin Gesù, Czech Lymphoma Study Group, Charite University, Berlin, Germany, Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León, University of Bologna, Hannover Medical School, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Toscana Life Sciences Sviluppo s.r.l., Lithuanian University of Health Sciences, Gruppo Italiano Malattie EMatologiche dell'Adulto, TIMELEX
Acute Myeloid Leukemia, Relapse/Recurrence
01/28
01/28
NCT06652438: Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

Not yet recruiting
3
415
Europe
Revumenib, Placebo
Stichting Hemato-Oncologie voor Volwassenen Nederland, German-Austrian Acute Myeloid Leukemia Study Group, United Kingdom AML Research Network
Acute Myeloid Leukemia, Adult
05/28
05/31
AMLSG BiO, NCT01252485: Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms - the Biology and Outcome (BiO)-Project

Recruiting
N/A
50000
Europe
University of Ulm
Acute Myeloid Leukemia (AML), MDS/AML
12/44
12/44

Download Options